Eciskafusp Alfa

DRUG2 trials

Sponsors

Hoffmann-La Roche

Conditions

Non-muscle Invasive Bladder CancerSolid Tumors

Phase 1

A Study to Evaluate Safety and Anti-Tumor Activity of Eciskafusp Alfa (RO7284755) Alone or in Combination With Atezolizumab in Participants With Advanced and/or Metastatic Solid Tumors

TerminatedNCT04303858

Hoffmann-La RocheSolid Tumors

Start: 2020-05-04End: 2025-10-02Updated: 2026-06-02

A Study to Evaluate Eciskafusp Alfa in Combination With Bacillus Calmette-guerin (BCG) in Participants With BCG-unresponsive High-risk Non-muscle Invasive Bladder Cancer (NMIBC)

WithdrawnNCT06816017

Hoffmann-La RocheNon-muscle Invasive Bladder Cancer

Start: 2025-06-15End: 2030-10-31Updated: 2025-06-16